✨ Medicines and Financial Reporting Approvals
NEW ZEALAND GAZETTE, No. 60 — 30 JUNE 2016
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Oxycodone Sandoz
Oxycodone hydrochloride 40mg
Modified release tablet
Novartis New Zealand Limited
Salutas Pharma GmbH, Barleben, Germany
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Oxycodone Sandoz
Oxycodone hydrochloride 80mg
Modified release tablet
Novartis New Zealand Limited
Salutas Pharma GmbH, Barleben, Germany
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Sunvepra
Asunaprevir 100mg
Capsule
Bristol-Myers Squibb (NZ) Limited
Catalent Pharma Solutions LLC, Florida, United States of America
Dated this 24th day of June 2016.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2016-go3673
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Dipeptiven
Alanylglutamine 200mg/mL
Concentrate for infusion
Fresenius Kabi New Zealand Limited
Fresenius Kabi Austria GmbH, Graz, Austria
Dated this 24th day of June 2016.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2016-go3674
Approval of Qualified Person for the Purposes of Section 36(1)(d)(ii) of the Financial Reporting Act 2013
I am satisfied that the individuals named below satisfy the requirements prescribed for the purposes of section 36A(2)(a) of the Financial Reporting Act 2013 and pursuant to section 36(1)(d)(ii) of that Act, I approve:
Allenby, Christopher Phillip, of Sydney, Australia, ASIC Registered Auditor No. 328257 and a member of Chartered Accountants Australia and New Zealand
Aman, Timothy Robert, of Sydney, Australia, ASIC Registered Auditor No. 482527 and a member of Chartered Accountants Australia and New Zealand
Ball, Darren Stephen, of Adelaide, Australia, ASIC Registered Auditor No. 334716 and a member of Chartered Accountants Australia and New Zealand
Barker, Tracey Louise, of Brisbane, Australia, ASIC Registered Auditor No. 424936 and a member of Chartered Accountants Australia and New Zealand
Batsakis, Tony, of Melbourne, Australia, ASIC Registered Auditor No. 283177 and a member of Chartered Accountants Australia and New Zealand
Beevers, Matthew Clifford, of Perth, Australia, ASIC Registered Auditor No. 320235 and a member of Chartered Accountants Australia and New Zealand
65
Next Page →
NZ Gazette 2016, No 60
✨ LLM interpretation of page content
🏥
Consent to the Distribution of New Medicines
(continued from previous page)
🏥 Health & Social WelfareMedicines, Distribution, Consent, Medicines Act 1981
🏥 Consent to the Distribution of a New Medicine
🏥 Health & Social Welfare24 June 2016
Medicines, Distribution, Consent, Medicines Act 1981
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
💰 Approval of Qualified Persons for Financial Reporting
💰 Finance & RevenueFinancial Reporting, Auditors, Approval, Chartered Accountants
6 names identified
- Christopher Phillip Allenby, Approved as qualified person for Financial Reporting Act 2013
- Timothy Robert Aman, Approved as qualified person for Financial Reporting Act 2013
- Darren Stephen Ball, Approved as qualified person for Financial Reporting Act 2013
- Tracey Louise Barker, Approved as qualified person for Financial Reporting Act 2013
- Tony Batsakis, Approved as qualified person for Financial Reporting Act 2013
- Matthew Clifford Beevers, Approved as qualified person for Financial Reporting Act 2013